Updated Review: Tamiflu Is a Bust
After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.
I mentioned Tamiflu and its uselessness when I complained about the uselessness of the flu vaccine, it seems like further study has only confirmed this:
An international team found that while Tamiflu might reduce the duration of flu symptoms by half a day, there’s no evidence that it reduces hospital admissions or complications of an infection. On top of that, the antiviral’s side effects include nausea and vomiting. “There is no credible way these drugs could prevent a pandemic,” …
Predictably, Roche (the developer) had this to say:
Roche stands by the utility of Tamiflu. “We fundamentally disagree with the overall conclusions” of the review, the company told MedPage Today. And others have said that the results don’t necessitate an end to stockpiling the drug. Sabrina Spinosa of the European Medicines Agency (EMA), which approved the use of Tamiflu in 2002, told Nature that the agency had reviewed the same clinical trial reports. “The review does not raise any new concerns,” she said, adding that the EMA maintains its position on the risks and benefits of Tamiflu.
Move over military industrial complex, the pharmaceutical industrial complex is now the boss!